Subsequent Meningiomas Among Survivors of Childhood Cancer
JAMA Network Open · 11.12.2025 · 8 (12) · e2548715
DOI: 10.1001/jamanetworkopen.2025.48715 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 11.12.2025. Verfasst von Daniel C Bowers und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology/Oncology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical School, Dallas. Hauptthemen laut MEDLINE: Meningioma, Cancer Survivors, Meningeal Neoplasms, Neoplasms, Second Primary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Importance Associations with chemotherapy, occurrence of multiple meningiomas, and mortality after subsequent meningioma diagnosis among survivors of childhood cancer remain unclear.
Objectives
To report the incidence of meningioma among childhood cancer survivors, identify novel risk factors for meningiomas, characterize survivors with multiple meningiomas, and describe cause-specific mortality following meningioma occurrence. Design, Setting, and Participants The Childhood Cancer Survivor Study is a retrospective cohort study with longitudinal prospective follow-up of childhood cancer survivors diagnosed between 1970 to 1999 in the US and Canada. Eligibility included diagnosis of cancer before age 21 years and surviving more than 5 years after diagnosis. Meningiomas were self-reported and confirmed by review of pathology reports. Childhood cancer diagnosis, chemotherapy details, and radiation therapy exposures from up to 5 years from diagnosis were abstracted from medical records. Main Outcomes and Measures Cumulative incidence of meningioma was calculated starting from 5 years from the diagnosis. Overall survival (OS) from diagnosis of the first subsequent meningioma was estimated using Kaplan-Meier methods.
Results
The CCSS cohort included 24 886 survivors initially diagnosed from 1970 to 1999, including 471 survivors (263 female [56%]; median [range] age at last follow-up, 42.5 [19.7-66.3] years; median [range] age at primary cancer diagnosis, 5.6 [0-20.9] years) who were diagnosed with 710 meningiomas. Thirty-five years after primary cancer diagnosis, the cumulative incidence of a subsequent meningioma was 2.3% (95% CI, 2.1%-2.6%). Of the 471 survivors who developed meningioma, 137 (29.0%) had at least 2 meningiomas, and 80 (16%) met criteria for meningiomatosis. An increased risk of meningioma was associated with higher doses of cranial radiation therapy (eg, HR, 125.3 [95% CI, 58.1-270.5]), younger age at primary cancer diagnosis (eg, 0 to 4 years: HR, 4.0 [95% CI, 2.4-6.1]), female sex (HR, 1.6 [95% CI, 1.3-1.9]), and exposure to platinum, antimetabolite chemotherapy, and intrathecal chemotherapy, and a lower risk was associated with non-Hispanic Black race (HR, 0.5 [95% CI, 0.3-1.0]) and exposure to alkylating agents (HR, 0.6 [95% CI, 0.5-0.8]). The all-cause cumulative mortality was 4.9%, 10.5% and 18.4% at 5, 10, and 15 years from the first subsequent meningioma diagnosis. Conclusions and Relevance Meningiomas have a relatively high incidence and mortality for childhood cancer survivors. Results from this study could justify screening for meningiomas in high-risk populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Pediatric Hematology/Oncology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical School, Dallas.
- Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.
- Tango Therapeutics, Boston, Massachusetts.
- St Jude Children's Research Hospital, Memphis, Tennessee.
- University of Alberta, Edmonton, Alberta, Canada.
- University of Minnesota, Minneapolis.
Förderung
- NCI NIH HHS
Zitieren
APA
Bowers, D. C., Cooney, T., Chen, Y., Yuan, Y., Galvin, R., Im, C., Leisenring, W., Brady, S. W., Smith, S. A., Howell, R. M., Arnold, M. A., Conces, M., Yasui, Y., Diller, L. R., Armstrong, G. T., Neglia, J. P., & Turcotte, L. M. (2025). Subsequent Meningiomas Among Survivors of Childhood Cancer. JAMA Network Open, 8(12), e2548715. https://doi.org/10.1001/jamanetworkopen.2025.48715
Vancouver
Bowers DC, Cooney T, Chen Y, Yuan Y, Galvin R, Im C, et al. Subsequent Meningiomas Among Survivors of Childhood Cancer. JAMA Network Open. 2025;8(12):e2548715. doi:10.1001/jamanetworkopen.2025.48715
BibTeX
@article{Bowers2025,
author = {Bowers, Daniel C and Cooney, Table and Chen, Yan and Yuan, Yan and Galvin, Robert and Im, Cindy and Leisenring, Wendy and Brady, Samuel W and Smith, Susan A and Howell, Rebecca M and Arnold, Michael A and Conces, Miriam and Yasui, Yutaka and Diller, Lisa R and Armstrong, Gregory T and Neglia, Joseph P and Turcotte, Lucie M},
title = {Subsequent Meningiomas Among Survivors of Childhood Cancer},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {12},
pages = {e2548715},
doi = {10.1001/jamanetworkopen.2025.48715}
}
EUVIMED